Jim Kramer here to share a short preview of my take on the market from today's

members-only CBC Investing Club morning meeting.

Join the club for full access to the morning meeting every day at 1020 a.m.

Visit Cmbc.com slash morning take to sign up today.

That's one word, morning tape.

We did make some trades yesterday, taking profits in Goldman Sachs after a nice come

back off of its lows, big position there.

So a little bit of right sizing.

We plowed that cash into J&J.

Some healthcare names still struggling in this tape.

Yeah, I mean, we're being behind me Putin and buying this down. Now, do I think it's going to

return to this? I do think that that this is one where you're going to wake up one day and

Jay J's going to be at 300. I don't know what to do.

I don't want to walk away from a whole sector, the second biggest sector, that has a lot of opportunity that is just out of favor for now.

In the same way, I didn't want to get rid of Microsoft at 390. Yeah, well, at least the fundamentals are good.

Had a good quarter, had some good news on its robotic surgery system the other day that's gone on notice.

So that is what gives us confidence to keep buying gradually.

And Bristol Myers, we left and we battle.

Right, it was a replacement.

I want to emphasize that.

We were taking out Bristol Myers, which was still a larger position than I think what J&J currently is. Yes, because we're being prudent. Now, I do want to talk about arm holdings because I think it's very confusing people.

Arm holdings went up a gigantic amount. After hours, it went up even more. Now, after hours,

...